PATENT CLAIM ANALYSIS

Application Number: 16206816
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["424", "093100"]

Abstract:
The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.

Claim (Index 17):
The method of  claim 14 , wherein the soluble fraction comprises a molecular weight fraction comprising molecules having a molecular weight less than 30,000 Daltons.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 98.0
- Lexical Diversity: 1.86111
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12822126', '12363479', '15362261', '14711646', '12632721']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7825505720029192
- 35 USC 102 Novelty (BERT): 0.6096708835450695
- Combined Prediction Score: 0.7652626031571342
- Mean Citation Score: 528.459938
- Max Citation Score: 578.1101
- Similarity Product: 471.59596899861685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test